What intravenous (IV) antibiotics should be given to a patient with a perforated tympanic membrane and probable mastoiditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Antibiotic Recommendations for Perforated Tympanic Membrane with Probable Mastoiditis

For a patient with perforated tympanic membrane and probable mastoiditis, initiate IV antibiotics targeting S. pneumoniae, H. influenzae, and S. aureus, with ceftriaxone 1-2g IV daily being the preferred agent based on contemporary treatment algorithms for acute mastoiditis. 1

Primary IV Antibiotic Selection

Ceftriaxone is the first-line IV antibiotic for mastoiditis, administered at 1g IV/IM daily for 5 days in adults, or 50 mg/kg/day in pediatric patients. 1, 2 This recommendation is based on:

  • Broad spectrum coverage against the three major pathogens causing mastoiditis: S. pneumoniae (most common), H. influenzae, and M. catarrhalis, plus coverage for S. aureus which accounts for 13-14% of culture-positive mastoiditis cases. 1, 3

  • Excellent tissue penetration with CSF concentrations of 5.6-6.4 mcg/mL in inflamed meninges, which is critical given the 7-16% risk of intracranial complications in mastoiditis. 2, 3

  • Once-daily dosing that facilitates compliance and allows for potential outpatient parenteral therapy in selected cases. 2

Alternative IV Antibiotic Options

If ceftriaxone is contraindicated or the patient has received recent beta-lactam therapy:

  • IV fluoroquinolones (levofloxacin 500-750mg daily or moxifloxacin 400mg daily) provide excellent coverage and have documented efficacy in serious otologic infections, including one reported mastoiditis case. 1, 4

  • Ceftazidime 1-2g IV every 8-12 hours is an alternative third-generation cephalosporin with proven efficacy in mastoiditis, though it has less pneumococcal coverage than ceftriaxone. 4

Critical Pathogen Considerations

The bacteriology of mastoiditis differs significantly from uncomplicated acute otitis media, which is why empiric coverage must be broader. 3 Culture data from 223 mastoiditis cases revealed:

  • S. pneumoniae (16% of positive cultures) 3
  • S. pyogenes (15% of positive cultures) 3
  • Methicillin-sensitive S. aureus (14% of positive cultures) - this is notably higher than in simple AOM 3, 5
  • Pseudomonas aeruginosa (9% of positive cultures) 3
  • Mixed flora (11% of cases) 3

Importantly, 54% of mastoiditis patients had already received oral antibiotics for 1-21 days before developing mastoiditis, indicating that oral therapy failure is common and IV antibiotics are necessary. 3

Treatment Algorithm

  1. Obtain cultures before starting antibiotics whenever possible through myringotomy or tympanocentesis, as the diversity of organisms and increasing antibiotic resistance makes culture-directed therapy valuable. 3

  2. Start empiric IV ceftriaxone immediately without waiting for culture results, given the risk of complications. 1

  3. Perform early myringotomy with or without tympanostomy tube placement, as this appears to decrease complication rates and facilitates drainage. 3, 6

  4. Reassess at 48-72 hours: If no clinical improvement, obtain CT imaging to evaluate for coalescent mastoiditis, subperiosteal abscess, or intracranial extension, and consider mastoidectomy. 1, 6

  5. Adjust antibiotics based on culture results if obtained, particularly if S. aureus or Pseudomonas is isolated. 3

Special Considerations for the Perforated Tympanic Membrane

While treating the mastoiditis with IV antibiotics:

  • Add topical fluoroquinolone drops (ciprofloxacin-dexamethasone or ofloxacin) to the perforated ear, as these are non-ototoxic and achieve concentrations 100-1000 times higher than systemic antibiotics at the local infection site. 7, 8

  • Avoid aminoglycoside-containing drops (neomycin, gentamicin, polymyxin B) completely, as they cause permanent sensorineural hearing loss through the perforation. 7, 8

  • Keep the ear dry and avoid irrigation, as introducing water through the perforation can worsen infection. 7, 8, 9

Duration of IV Therapy

Continue IV antibiotics until clinical improvement is evident (typically 48-72 hours), then consider transition to high-dose oral amoxicillin-clavulanate (4g/250mg daily in adults, 90mg/6.4mg/kg/day in children) to complete a total 10-14 day course. 1 The total duration depends on:

  • Presence of complications (longer courses needed) 3
  • Response to therapy (persistent fever or symptoms warrant continued IV therapy) 1
  • Whether surgical intervention was required (mastoidectomy cases may need longer treatment) 6

Common Pitfalls to Avoid

  • Do not rely on oral antibiotics alone for mastoiditis, as 54% of patients develop mastoiditis despite oral antibiotic treatment for AOM. 3

  • Do not delay imaging beyond 48-72 hours if the patient is not improving, as 16/223 (7%) of mastoiditis cases present with intracranial complications requiring urgent surgical intervention. 3

  • Do not use ototoxic ear drops in the perforated ear while treating mastoiditis - this is a separate but critical consideration that can cause permanent hearing damage. 7, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute mastoiditis--the antibiotic era: a multicenter study.

International journal of pediatric otorhinolaryngology, 2001

Research

Acute coalescent mastoiditis and acoustic sequelae in an infant with severe congenital neutropenia.

International journal of pediatric otorhinolaryngology, 2002

Research

Value of computed tomography of the temporal bone in acute otomastoiditis.

Revue de laryngologie - otologie - rhinologie, 1998

Guideline

Management of Tympanic Membrane Perforation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Asymptomatic Ruptured Ear Drum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The perforated tympanic membrane.

American family physician, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.